A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD
Clinical trial NCT05972473 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05972473
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-21
- Primary completion
- 2027-02-28
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.